Atlas Trials

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Clinical trial NCT03548987 · COMPLETED

Trial details

NCT number
NCT03548987
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metabolism and Nutrition DisorderObesity
Start date
2018-06-04
Primary completion
2020-02-22
Enrollment
902

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.